
Glimepiride (1mg)
Rayax Drug India
Glimepiride 1mgPack Size
Strip of 10 tablets
Price
Save ₹9
that's 23% off!
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimblist 1 Tablet contains Glimepiride 1 mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride acts by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. It is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise, to achieve optimal blood glucose levels. The onset of action is gradual, with a duration that supports once-daily dosing, enhancing patient compliance. Glimblist 1 Tablet is suitable for use as monotherapy or in combination with other antidiabetic agents when diet and lifestyle modifications alone are insufficient. Caution is advised in patients with hepatic or renal impairment, and it should be used with care in elderly patients due to the increased risk of hypoglycemia. Common adverse effects include hypoglycemia, gastrointestinal disturbances, and allergic reactions. Regular monitoring of blood glucose and periodic assessment of renal and hepatic function are recommended during therapy. Glimblist 1 Tablet should be used under medical supervision, with dosage adjustments based on clinical response and tolerability to ensure safe and effective diabetes management.
How to use Glimblist Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimblist 1 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimblist 1 Tablet.
High Risk
Glimblist 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimblist 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimblist 1 Tablet may be needed. Please consult your doctor. However, the use of Glimblist 1 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimblist 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimblist 1 Tablet
Consult Doctor
Glimblist 1 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimblist 1 Tablet may be needed. Please consult your doctor. Use of Glimblist 1 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimblist 1 Tablet

Glimepiride (1mg)
Rayax Drug India
Glimepiride 1mgPack Size
Strip of 10 tablets
Price
Save ₹9
that's 23% off!
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimblist 1 Tablet contains Glimepiride 1 mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride acts by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. It is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise, to achieve optimal blood glucose levels. The onset of action is gradual, with a duration that supports once-daily dosing, enhancing patient compliance. Glimblist 1 Tablet is suitable for use as monotherapy or in combination with other antidiabetic agents when diet and lifestyle modifications alone are insufficient. Caution is advised in patients with hepatic or renal impairment, and it should be used with care in elderly patients due to the increased risk of hypoglycemia. Common adverse effects include hypoglycemia, gastrointestinal disturbances, and allergic reactions. Regular monitoring of blood glucose and periodic assessment of renal and hepatic function are recommended during therapy. Glimblist 1 Tablet should be used under medical supervision, with dosage adjustments based on clinical response and tolerability to ensure safe and effective diabetes management.
How to use Glimblist Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimblist 1 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimblist 1 Tablet.
High Risk
Glimblist 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimblist 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimblist 1 Tablet may be needed. Please consult your doctor. However, the use of Glimblist 1 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimblist 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimblist 1 Tablet
Consult Doctor
Glimblist 1 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimblist 1 Tablet may be needed. Please consult your doctor. Use of Glimblist 1 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimblist 1 Tablet













